Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Visudyne T-IND program expanded

March 20, 2000

InSite Vision's batimastat eyedrops show antiangiogenic activity

March 20, 2000

Ciba Vision seeks approval of Rescula on two continents for treatment of glaucoma

March 14, 2000

Alocril now available in U.S. for itch associated with allergic conjunctivitis

March 2, 2000

Santen seeks FDA approval of levofloxacin for bacterial conjunctivitis

March 1, 2000

Allergan and Dura enter commercialization agreement for multiple products

Feb. 25, 2000

GenVec licenses gene for treating blindness

Feb. 24, 2000

Oxigene to develop CA4P for eye, skin and joint disorders

Feb. 23, 2000

New selectin inhibitor SKK-60060 shows promise in treatment of uveitis

Feb. 22, 2000

Blockade of VEGF alone is sufficient to prevent blinding illness

Feb. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...